Breast Cancer

Current Insights: Evolving Principles and Controversies of Cancer Risk Assessment and Management of Hereditary Cancers

There is currently a lack of evidence regarding proper procedures and risk management strategies that should follow multi-gene testing, especially when pathogenic or likely pathogenic variants are found for moderate-penetrance genes and when a variant of unknown significance (VUS) is found.

Management of Toxicities with Targeted Therapies for Breast Cancer

Staying up-to-date with the available treatment options is important to clinicians integrating new evidence-based data into their clinical practice, and being familiar with their toxicity profiles is important to optimize patient outcomes.

Management of Metastatic Breast Cancer, Including SABCS Updates

The decision-making process for metastatic breast cancer should involve a detailed discussion with patients of the benefits and risks associated with all possible treatment strategies.

Biomarker Assays for Treatment Selection of Advanced Breast Cancer

Biomarkers identify patients who are likely to respond to a given therapy. These assays and their interpretation can present challenges for clinicians.

Management of Rare Breast Cancers

The management of rare breast cancer subtypes represents a challenge in clinical practice.

Principles of Breast Reconstruction after Surgery

All women undergoing breast cancer treatment should be educated about breast reconstructive options as adapted to their individual clinical situation and be offered an opportunity to consult with a reconstructive plastic surgeon. Coordinating consultation and surgical treatment with a reconstruct

Is There a Role for Proton Therapy in the Treatment of Breast Cancer?

Locoregional management strategies have considerably evolved. Considerable progress has been made in understanding which patients will benefit from radiation therapy and ways to administer treatment that maximize clinical benefit while minimizing toxicity; however, many controversies exist as we

Surgical Management of Breast Cancer, Including SABCS Updates

Locoregional management strategies have considerably evolved.

Adjuvant and Neoadjuvant Therapies for Early Stage Breast Cancer, Including SABCS Updates

Clinicians are challenged to stay up-to-date on new approaches and options for neoadjuvant /adjuvant systemic therapy so they can provide appropriate care using a shared decision making process with the patient, taking into account patient and disease characteristics including risk of recurrence, and weighing the potential benefits and risks of each option. In addition, it is important for clinicians to be aware of new supportive care interventions available to improve the quality of life of patients.

Genetics/Familial Risk Assessment for Breast Cancer: Controversies and Evolving Principles